PointCheck is a portable, fast, and non-invasive white cell monitoring device.
The device works on the principle of imaging the blood flow and counting the number of white blood cells. PointCheck™ is a non-invasive device which allows immunosuppressed patients to get their blood check done. The device will potentially help health clinics in having more frequent and rapid testing done. Currently this is an investigational device and it is not for sale.
Planning to distribute in Boston
Primary competitor includes cell counting devices developed by Fisher Scientific.
Goal 3: Good health and well-being
Health care providers
Leuko is working on developing prototypes and commercializing the technology with help from the MIT Innovation Initiative, the MIT Deshpande Center for Technological Innovation, the MIT Sandbox Innovation Fund, the Martin Trust Center for Entrepreneurship, the MIT Translational Fellows Program, and the MIT Venture Mentoring Service.
This product is in the prototype phase and is not available for distribution yet.
The design of the device allows chemotherapy patients to prevent infections from needle-based tests. The device uses imaging technique which is non-invasive and thus quick check on white blood cell count can be done. The device is portable enough to be used in a clinic or home applications where the patient can have access to daily checks on their blood count. The device is enclosed in a plastic casing and is suitable for use in the home, clinic, or healthcare centers.
Replaceable component includes the battery
Accurately measure white blood cell levels.
The team showed that the device could accurately determine whether white blood cell levels were too low, in a study of 11 patients undergoing chemotherapy.
Testing performed by the manufacturer, however, no third-party testing has been completed.
No known safety hazards are related to this product.
A reliable power source is required for the device to function and read the blood flow.
Tajiri, J., Noguchi, S., Murakami, T. and Murakami, N., 1990, Antithyroid drug–induced agranulocytosis: the usefulness of routine white blood cell count monitoring, Archives of internal medicine, 150(3), pp. 621-624.
Bates, M.F., Khander, A., Steigman, S.A., Tracy, T.F. and Luks, F.I., 2014, Use of white blood cell count and negative appendectomy rate, Pediatrics, 133(1), pp. e39-e44.
Van’t Oever, R., et al, 2003, “Optical method and apparatus for red blood cell differentiation on a cell-by-cell basis, and simultaneous analysis of white blood cell differentiation.“, U.S. Patent No. 6,630,990.
The product was tested for its accuracy in detecting low white blood cell levels.
In context photographs (0)
You can use the form below to contribute a photo of this product.
In context files & documents (0)
Feedback from users, customers & distributors
Please let us know your experience in using this product through comments below.